Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doris Lindoerfer

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Blood|March 24, 2012
The EUTOS CML score aims to support clinical decision-makingVerena Hoffmann, Michele Baccarani, Joerg Hasford, et al.
Blood|May 4, 2011
Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS scoreJoerg Hasford, Michele Baccarani, Verena Hoffmann, et al.
Genome Medicine|July 17, 2021
Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer modelsDeepak Vangala, Swetlana Ladigan, Sven T Liffers, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Blood|March 24, 2012
The EUTOS CML score aims to support clinical decision-makingVerena Hoffmann, Michele Baccarani, Joerg Hasford, et al.
Blood|May 4, 2011
Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS scoreJoerg Hasford, Michele Baccarani, Verena Hoffmann, et al.
Genome Medicine|July 17, 2021
Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer modelsDeepak Vangala, Swetlana Ladigan, Sven T Liffers, et al.
Pageof 2